Lung Health After Tuberculosis: Clinical and Functional Assessment in Post Pulmonary Tuberculosis Egyptian Patients.
- Conditions
- Pulmonary Function; Newborn, AbnormalPulmonary Tuberculoses
- Registration Number
- NCT05097638
- Lead Sponsor
- Assiut University
- Brief Summary
Some of pulmonary tuberculous patients who completed their medication course experience lung function impairment
- Detailed Description
Some of pulmonary tuberculous patients who completed their medication course experience lung function impairment which may influence their quality of life. However, the pattern and nature of post-tuberculosis lung impairment is still not identified. Thus, the aim of this study was to determine the type and degree of lung physiology changes in previously treated tuberculous patients which latter may affect their quality of life; thus helping clinicians for early diagnosis of lung impairment, especially in tuberculous endemic areas.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 210
- Patient completed an outpatient course of standard first line anti-tuberculosis therapy and declared as cured
- Smoker (to avoid spirometry biases).
- Extrapulmonary tuberculosis cases
- Multidrug resistant tuberculosis
- known contraindications to spirometry testing
- Individuals with chest wall deformities or neuromuscular diseases
- Patients who failed to achieve acceptability and reproducibility criteria of the spirometry test
- Defaulter cases or irregular treatment,
- known coexisting chronic lung disease as history of asthma or interstitial lung diseases
- A history of illicit drug use
- Patients with comorbidities: renal and hepatic insufficiency, heart diseases and metabolic disorders.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Post tuberculosis lung functional impairment 6 months spirometry abnormality either: restrictive, obstructive, or mixed
Grading of obstruction function: 6 months grading according to GOLD : mild , moderate , severe , very severe
post tuberculosis persistent clinical symptoms 6 months either cough , sputum , breathlessness, hemoptysis
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Chest Department-faculty of medicine-Assuit university
🇪🇬Assuit, Egypt
Chest Department-faculty of medicine-Assuit university🇪🇬Assuit, Egypt